United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?
Tommy G. ThompsonDirector2023-06-021,000$88.03
Tommy G. ThompsonDirector2023-06-021,000$217.22
Paul A. MahonEVP GENERAL COUNSEL2023-06-01400$207.01
Paul A. MahonEVP GENERAL COUNSEL2023-06-012,750$208.79
Paul A. MahonEVP GENERAL COUNSEL2023-06-012,850$209.72
Paul A. MahonEVP GENERAL COUNSEL2023-06-016,000$120.26
Richard GiltnerDirector2023-05-225,000$63.90
Richard GiltnerDirector2023-05-225,000$218.59
Paul A. MahonEVP GENERAL COUNSEL2023-05-182,994$214.27
Paul A. MahonEVP GENERAL COUNSEL2023-05-186,000$120.26

1 of 107

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?
Lilly Co Eli11.21%5,251,394$1.15BInsider
Blackrock Inc10.14%4,751,961$1.04BInstitution
Vanguard Group Inc9.83%4,605,917$1.01BInstitution
Wellington Management Group LLP8.07%3,781,840$827.77MInstitution
Avoro Capital Advisors LLC6.13%2,870,000$628.19MInstitution
Fmr LLC5.42%2,537,457$555.40MInstitution
Renaissance Technologies LLC4.75%2,227,414$487.54MInstitution
State Street Corp3.83%1,795,102$392.91MInstitution
Janus Henderson Group PLC2.08%975,830$213.59MInstitution
Martine A. Rothblatt1.77%827,110$181.04MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR87.71%12.29%Net SellingNet Selling
APLS74.31%25.69%Net BuyingNet Buying
RXDX66.00%34.00%Net SellingNet Selling
NBIX69.22%30.78%Net SellingNet Selling

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 95.14% institutional shareholders, 13.33% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.21% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $1.16B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.